Find similar products:
The text only version may be available in large print, Braille or audio CD. For further information call emc accessibility on 0800 198 5000. The product code(s) for this leaflet is: PL 00065/0159.
Cerazette 75 microgram film-coated tablet
Cerazette®
75 microgram film-coated tablets
desogestrel
1. What Cerazette is and what it is used for
2. What you need to know before you take Cerazette
Do not take…
Warnings and precautions
Pregnancy and breast-feeding
3. How to take Cerazette
Starting your first pack
Changing from other methods
After a baby
If you forget to take Cerazette
4. Possible side effects
5. How to store Cerazette
6. Contents of the pack and other information
Cerazette, like other hormonal contraceptives, does not protect against HIV infection (AIDS) or any other sexually transmitted disease.
If any of these conditions apply to you, tell your doctor before you start to use Cerazette. Your doctor may advise you to use a non-hormonal method of birth control.
If any of these conditions appear for the first time while using Cerazette, consult your doctor immediately.
Before you start Cerazette tell your doctor or Family Planning Nurse, if
When Cerazette is used in the presence of any of these conditions, you may need to be kept under close observation. Your doctor can explain what to do.
Breast cancer is rare under 40 years of age but the risk increases as the woman gets older.
Therefore, the extra number of breast cancers diagnosed is higher if a woman continues to take the Pill when she is older. How long she takes the Pill is less important.
The risk of breast cancer in users of progestogen-only pills like Cerazette is believed to be similar to that in women who use the Pill, but the evidence is less conclusive.
Breast cancers found in women who take the Pill, seem less likely to have spread than breast cancers found in women who do not take the Pill.
It is not certain whether the Pill causes the increased risk of breast cancer. It may be that the women were examined more often, so that the breast cancer is noticed earlier.
See your doctor immediately if you notice possible signs of a thrombosis (see also ‘Regular check-ups’).
Thrombosis is the formation of a blood clot, which may block a blood vessel. A thrombosis sometimes occurs in the deep veins of the legs (deep venous thrombosis). If this clot breaks away from the veins where it is formed, it may reach and block the arteries of the lungs, causing a so-called “pulmonary embolism”. A pulmonary embolism can cause chest pain, breathlessness, collapse or even death.
The risk is higher in Pill-users than in non-users. The risk with progestogen-only pills like Cerazette is believed to be lower than in users of Pills that also contain oestrogens (combined Pills).
Some women using hormonal contraceptives including Cerazette have reported depression or depressed mood. Depression can be serious and may sometimes lead to suicidal thoughts. If you experience mood changes and depressive symptoms contact your doctor for further medical advice as soon as possible.
No clinical data on efficacy and safety are available in adolescents below 18 years.
Tell your doctor, pharmacist, or Family Planning Nurse if you are taking, have recently taken or might take any other medicines or herbal products. Also tell any other doctor or dentist who prescribes another medicine (or your pharmacist) that you take Cerazette. They can tell you if you need to take additional contraceptive precautions (for example condoms) and if so, for how long or whether the use of another medicine you need must be changed.
Some medicines:
These include medicines used for the treatment of:
If you are taking medicines or herbal products that might make Cerazette less effective, a barrier contraceptive method should also be used. Since the effect of another medicine on Cerazette may last up to 28 days after stopping the medicine, it is necessary to use the additional barrier contraceptive method for that long. Your doctor can tell you if you need to take additional contraceptive precautions and if so, for how long.
Cerazette may also interfere with how other medicines work, causing either an increase in effect (e.g. medicines containing ciclosporin) or a decrease in effect (e.g. lamotrigine).
Ask your doctor or pharmacist for advice before taking any medicine.
Pregnancy
Do not use Cerazette if you are pregnant, or think you may be pregnant.
Breast-feeding
Cerazette may be used while you are breast-feeding. Cerazette does not appear to influence the production or the quality of breast milk. However, there have been infrequent reports of a decrease in breast milk production while using Cerazette. A small amount of the active substance of Cerazette passes over into the milk.
The health of children who were breast-fed for 7 months while their mothers were using Cerazette has been studied up until they were 2½ years of age. No effects on the growth and development of the children were observed.
If you are breast feeding and want to use Cerazette, please contact your doctor.
Cerazette has no known effect on the ability to drive or use machines
Cerazette contains lactose (milk sugar). Please contact your doctor before taking Cerazette if you have been told by your doctor that you are intolerant to some sugars.
When you are using Cerazette, your doctor will tell you to return for regular check-ups. In general, the frequency and nature of these check-ups will depend on your personal situation.
Contact your doctor as soon as possible if:
Each strip of Cerazette contains 28 tablets – 4 weeks supply.
Wait for your period to begin. On the first day of your period take the first Cerazette tablet. Additional contraceptive precautions are not necessary. If you take your first tablet on days 2-5 of your period use an additional barrier method of contraception for the first 7 days of tablet-taking.
If you don’t have a tablet-, ring- or patch-free break
If you have a tablet-, ring- or patch-free break
Switch on any day from another mini-pill. Additional contraceptive precautions are not necessary.
Start using Cerazette when your next injection is due or on the day that your implant or your IUS is removed. Additional contraceptive precautions are not necessary.
You can start Cerazette between 21 to 28 days after the birth of your baby.
If you start later, make sure that you use an additional barrier method of contraception until you have completed the first 7 days of tablet-taking. However, if you have already had sex, check that you are not pregnant before starting Cerazette. Information for breast-feeding women can be found in section 2 ‘What you need to know before you take Cerazette’ in the paragraph ‘Pregnancy and breast-feeding’. Your doctor can also advise you.
Your doctor will advise you.
If you vomit within 3 - 4 hours after taking your Cerazette tablet or have severe diarrhoea, the active ingredient may not have been completely absorbed. Follow the advice for forgotten tablets in the section above.
There have been no reports of serious harmful effects from taking too many Cerazette tablets at one time. Symptoms that may occur are nausea, vomiting and in young girls, slight vaginal bleeding. For more information ask your doctor for advice.
You can stop taking Cerazette whenever you want. From the day you stop you are no longer protected against pregnancy.
If you have any further questions on the use of this product, ask your doctor or pharmacist.
Like all medicines, Cerazette can cause side effects, although not everybody gets them.
Tell your doctor if you notice any unwanted effect, especially if severe or persistent.
Serious side effects associated with the use of Cerazette are described in section 2 ‘What you need to know before you take Cerazette’. Please read this section for additional information on ‘Breast cancer’ and ‘Thrombosis’ and consult your doctor at once where appropriate.
You should see your doctor immediately if you experience allergic reactions (hypersensitivity), including swelling of the face, lips, tongue, and/or throat causing difficulty in breathing or swallowing (angioedema and/or anaphylaxis).
Vaginal bleeding may occur at irregular intervals while using Cerazette. This may be just slight staining which may not even require a pad, or heavier bleeding, which looks rather like a scanty period. You may need to use tampons or sanitary towels. You may also not have any bleeding at all. Irregular bleeding is not a sign that Cerazette is not working. In general, you need not take any action; just continue to take Cerazette. If bleeding is heavy or prolonged you should consult your doctor.
Common: may affect up to 1 in 10 women
Uncommon: may affect up to 1 in 100 women
Rare: may affect up to 1 in 1,000 women
Not known (cannot be estimated from the available data)
Apart from these side effects, breast secretion or leakage may occur.
If you get any side effects talk to your doctor, pharmacist or Family Planning Nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use after the expiry date which is stated on the package. The expiry date is the last day of the month stated.
This medicine does not require any special temperature storage conditions. Store the blister pack in the original sachet in order to protect from light and moisture. Use within 1 month from the date of first opening of the sachet.
The active substance shows an environmental risk to fish.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.
Each strip of Cerazette contains 28 white round tablets. The tablets are marked KV above 2 on one side and ORGANON* on the other. Cerazette comes in a pack of 1, 3, 6 or 13 strips. Each strip is sealed in a foil sachet. Not all pack sizes may be available.
This medicinal product is authorised in the Member States of the EEA under the following names:
Austria, Belgium, Denmark, Finland, Germany, Greece, Ireland, Italy, Luxembourg, Netherlands, Norway, Portugal, Sweden, United Kingdom: Cerazette.
Spain: Cerazet.
This leaflet was revised in April 2022.
In correspondence please quote packing number.
To listen to or request a copy of this leaflet in Braille, large print or audio please call, free of charge: 0800 198 5000 (UK Only)
Please be ready to give the following information:
Product name: Cerazette Reference Number: PL 00025/0562
This is a service provided by the Royal National Institute of Blind people.
© 2022 Organon group of companies. All rights reserved.
PIL.CER.22.UK.0066.IA-ORG-LDN.NORCN